SUMMARY The immediate effects of topical salbutamol, a beta2 adrenergic agonist, on the aqueous humour dyamics of 22 normal subjects was studied by fluorophotometry and tonography. Significant lowering of intraocular pressure was accompanied by a significant increase in both aqueous flow rate and tonographic facility of outflow. Uveoscleral outflow was calculated and found to be significantly increased by salbutamol. This appeared to be the predominant acute pressure lowering effect of beta receptor stimulation in the normal human eye.
Pharmacological manipulation of the adrenergic system within the eye plays an important part in the medical treatment of glaucoma. Timolol and adrenaline are widely used as ocular hypotensive agents and highlight the apparent paradox that both stimulation and blockade of adrenoceptors result in lowering of the intraocular pressure.
Fluorophotometric studies' 2 have shown that timolol, a beta, and beta, antagonist lowers the intraocular pressure by reducing the rate of aqueous formation. It has little or no effect on aqueous outflow. 3 4 Recent studies5" on the effect of adrenaline, a mixed alpha, beta,, and beta2 agonist, have revealed more complex actions. Intraocular pressure is reduced, in spite of an increase in aqueous formation, by an increase in aqueous outflow, which appears to be predominantly through the uveoscleral pathway. Bill7 had earlier found a similar effect in monkeys with isoprenaline, a predominantly beta agonist. This increase in uveoscleral outflow is thought to be due to beta receptor mediated ciliary muscle relaxation.
Salbutamol is a relatively specific beta2 agonist that has been shown to have a significant ocular hypotensive effect in man.8 It was considered a suitable drug for investigating the effects of beta receptor stimulation on aqueous humour dynamics in the normal human eye. 
Subjects and methods
Twenty-two normal, young subjects, 13 male and 9 female, participated in the study. Each subject underwent a full eye examination and met the admission criteria that both eyes were normal except for ametropia and that the intraocular pressure of the two eyes differed by 3 mmHg or less.
The study was divided into two parts separated by a minimum period of two weeks. In the first part the effect of salbutamol on aqueous flow was measured by fluorophotometry; in the second part the effect on tonographic facility of outflow was measured.
In both parts of the study each subject acted as his or her own'control, receiving randomly assigned drug solution to one eye and placebo solution to the other. The study was carried out in a double-masked fashion.
Salbutamol sulphate solution, equivalent to 4% salbutamol base, and placebo vehicle solution were prepared by the hospital pharmacy and placed in drug-placebo bottle pairs labelled according to a code retained by the pharmacy until the end of the study.
FLUOROPHOTOMETRIC-STU DY
On the morning of the study the volume of the anterior chamber of each eye was determined by a photogrammetric method, ' Table 1 gives the results of the aqueous flow study. Table 2 gives the results of the outflow facility study. Statistical analysis of both studies is given in Table 3 .
Salbutamol-treated eyes showed a statistically significant increase in aqueous flow rate of 39% and a statistically significant decrease in intraocular pressure compared with the placebo-treated eyes. Facility of outflow increased by 42% in the salbutamol-treated eyes but also increased significantly, by 21%, in the placebo-treated eyes.
Calculated values for trabecular outflow (F,ri,b) and uveoscleral outflow are given in Table 4 . 
Finail mcasurcment. NS=Not significant (p>().()5).
The results of the iris diffusion study are given in Table 5 . Fluorescein loss from the anterior chamber increased by approximately one-third in the salbutamol-treated eyes.
Discussion
The results of this study show that the immediate effect of salbutamol is to increase the rate of flow of aqueous humour and to increase the rate of outflow. The net effect of these conflicting actions is to lower intraocular pressure.
The rate of flow of aqueous humour has been calculated on the assumption that 90% of fluorescein loss from the anterior chamber is by bulk flow and the The effect of salbutamol on aqueous outflow is more complex. For the purpose of calculating outflow through the trabecular meshwork and through the uveoscleral route a value of 8 mmHg has been assumed for the episcleral venous pressure which was not measured in the study. Further, it has been assumed that salbutamol does not significantly alter P,.V Careful and repeated measurements by Kupfer and his co-workers'l(-failed to show any significant effect of adrenergic agonists, including the predominantly beta agonist isoprenaline, on P,. after one hour. Transient but unimportant effects may have occurred, and delayed effects after one hour cannot be ruled out, but it seems unlikely that topically applied beta agonists cause a significant reduction in
PCV
The increase in tonographic facility of outflow with salbutamol is consistent with the finding of Langham and Diggs"' that a 2% solution results in a 60% increase in C at 6 hours. Paterson and Paterson,' using a 4% solution, found little or no change in C, but their measurements were taken at the end of one and two weeks' treatment. The significant increase in C that occurred in our placebo-treated eyes was unexpected and did not occur in the study by Langham and Diggs. In other studies'7 tonography repeated after a period as short as one hour has given identical results, and it is concluded that the significant increase in C in the control eye is drug induced, though the mechanism of this consensual response remains obscure.
In the placebo-treated eyes trabecular outflow (Ftrah) was unchanged in spite of the increase in C, because P,, fell during the course of the study. By contrast Fr,5 was reduced by 47% in the salbutamoltreated eyes-that is, less aqueous left these eyes via the pressure-dependent trabecular route despite the substantial increase in outflow facility.
For the purpose of calculating uveoscleral outflow it has been assumed that the facility of outflow measured at five hours is attained within one hour of instilling salbutamol and similarly the final intraocular pressures in the tonographic and fluorophotometric studies. The apparent increase in U in the salbutamoltreated eyes is approximately 160%, and more than three times the volume of aqueous leaves the salbutamol-treated eye by this pressure-insensitive route than via the trabecular meshwork and canal of Schlemm. Townsend and Brubaker' in their fluorophotometric study of the acute effect of adrenaline calculated that U had increased by 58% while Fl,1, was unchanged. The results of this study indicate that beta, receptors are present in the ciliary processes, the ciliary muscle, and trabecular meshwork of the human eye. Stimulation results in an immediate increase in aqueous formation, uveoscleral outflow, and tonographic facility of outflow. These effects are similar to those produced by adrenaline, suggesting that at least in the short term the beta2 agonist effect of adrenaline is dominant.
